BROADCASTS.com

In this week’s WashingtonWise Investor, Mike delves into the HEROES Act, the $3 trillion, “phase four” package of emergency spending proposals passed by the House of Representatives. Republicans in the Senate want a smaller package and favor including programs that protect businesses from litigation. With senators on both sides voicing the need for getting more relief soon, watch for some serious compromises to be struck in order to get the next round out the door.

Mike also looks at the push to delist Chinese companies from American stock exchanges over lack of transparency, considers what the new rules for voting by proxy in the House will mean, highlights efforts to simplify the small-business loan program, and discusses the likelihood of holding political conventions at the end of summer. He closes out with insights on the different approaches the New Your Stock Exchange and the SEC are employing to keep the markets operating during the coronavirus crisis.

WashingtonWise Investor is an original podcast from Charles Schwab. For more on the series, visit Schwab.com/WashingtonWise.

If you enjoy the show, please leave a ★★★★★ rating or review on Apple Podcasts. 

Important Disclosures

The policy analysis provided by the Charles Schwab & Co., Inc., does not constitute and should not be interpreted as an endorsement of any political party.

The information provided here is for general informational purposes only and should not be considered an individualized recommendation or personalized investment advice. 

All expressions of opinion are subject to change without notice in reaction to shifting market conditions. Data contained herein from third-party providers is obtained from what are considered reliable sources. However, its accuracy, completeness or reliability cannot be guaranteed.

Past performance is no guarantee of future results and the opinions presented cannot be viewed as an indicator of future performance.

Investing involves risk including loss of principal.

The Schwab Center for Financial Research is a division of Charles Schwab & Co., Inc. 

(0520-08YE)